Publications by authors named "A Altunsoy"
Article Synopsis
- * Out of 57 patients analyzed, significant clinical differences were observed between the treatment and untreated groups, but both groups had similar baseline demographic and laboratory characteristics.
- * The results indicated that while early antiviral therapy led to better short-term HBsAg seroclearance rates, it did not prevent chronic hepatitis B or significantly differ in key clinical outcomes, suggesting the need for further, larger randomized studies.
Prevalence of Cardiovascular Disease and Comparison of Risk Category Predictions of Systemic Coronary Risk Evaluation Score-2 and 4 Other Cardiovascular Disease Risk Assessment Tools Among People Living with Human Immunodefficiency Virus in Türkiye.
Anatol J Cardiol
October 2024
Article Synopsis
- Cardiovascular disease (CVD) significantly affects people living with HIV (PLWH), with this study finding a diagnosed CVD prevalence of 10.8% among 1425 participants aged 40-75.
- The assessment utilized five different risk evaluation tools, revealing that 42.8% of participants had a high 10-year risk of CVD, while 71.7% were classified as high- to very high-risk using the SCORE2 tool.
- The findings stress the need for better cardiovascular health monitoring and highlighted that current utilization of lipid-lowering therapy is inadequate, despite a large number of PLWH being eligible for such treatment per recent guidelines.
Tigecycline-Associated Hepatic Steatosis After Liver Transplant: A Case Report.
Exp Clin Transplant
April 2024
Tigecycline is a parenteral glycycline antibiotic that is used to treat severe infections caused by susceptible organisms, butitis also associated with hepatotoxicity. We present 2 similar patients with hepatic steatosis possibly associated with early tigecycline after transplant. In the first case, a 61-year-old woman underwent liver transplant for acute severe hepatitis; 6 days posttransplant, because of nonroutine resistant fever, the patient received tigecycline combined with daptomycin.
View Article and Find Full Text PDFIntroduction: This study aims to show the bacteriologic picture of acute prostatitis and bacteremia caused by infective agent after transrectal ultrasound-guided prostate biopsy (TRUSBx) and to determine the resistance rates of the infections in patients undergoing transrectal biopsy and to guide prophylaxis approach before biopsy.
Methodology: The retrospective data of 935 patients who underwent TRUSBx between January 2010 to January 2019 were reviewed. Pre-biopsy urine cultures and antimicrobial susceptibility were obtained.
A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome.
J Infect Dev Ctries
February 2024
Introduction: Coronavirus disease 2019 (COVID-19) can have symptoms like many neurological diseases, and one of the rare forms of these presentations is opsoclonus-myoclonus ataxia syndrome (OMAS). The pathogenesis of OMAS in adults has not been clearly elucidated and OMAS can be fatal.
Case Presentation: We present a 71-year-old male patient who was admitted to the emergency department with complaints of involuntary tremor-like movements in his hands, feet and mouth, and speech impediment for three days, and was followed up with COVID-19.